Collectively, these results strongly suggest that exogenous BMP4 may suppress hepatic steatosis and alleviate the development and progression of NAFLD by inhibiting mTORC1 signaling (Figure 7). The gene discussed is BMP4; the disease is metabolic dysfunction-associated steatotic liver disease.